menu
    • menu

    List of Certificates of Suitability (CEPs) for Active Pharmaceutical Ingredients (APIs) issued to ZACH System SA by EDQM. Original Data: EDQM Database

    ZACH System-PSE
    News
    Zcube Announces 5 Startups For New Edition Focused Women's Health

    10 Oct 2024

    // PRESS RELEASE

    Zambon Ventures Leads C$2 million investment In Health Innovation

    24 Sep 2024

    // PRESS RELEASE

    Zambon Phase 3 Study Shows Success In CMS I-neb Efficacy In NCFB

    13 Sep 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Zach System VB Read More

    Contact Supplier

    Website

    BOS Manchester

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/pnQL6oDh-KQ

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Products KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Related CompaniesRelated Companies

    About

    Zach System, a subsidiary of Zambon Company, specializes in providing active pharmaceutical ingredients (APIs), intermediates and custom synthesis services that align with customers’ schedules and budget targets. It offers a diverse range of products and services for the generic drugs market, including producing APIs for Zambon Pharma and offering process development expertise to customers. Its facility in Avrillè, France, is cGMP compliant and approved by the FDA. The facility boasts reactors ranging from 50 litres to 10,000 litres, advanced technologies, and a state-of-the-art R&D center and QC labs, as well as a dedicated sales team.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ZACH System SAFrance Flag
    Country
    Country
    France
    Address
    Address
    Z.l. la Croix Cadeau C.S 10079 49242 Avrille Cedex
    Telephone
    Telephone
    +33 676065210
    Client Email
    Email
    nicolas.girard@zambongroup.com
    Client Website
    Website
    https://www.zambon.com/en/production/zach-system
    Linkedin
    Linkedin
    https://in.linkedin.com/company/zach-system
    youtube
    YouTube
    https://www.youtube.com/channel/UCtibwDy2GE3-pFldM7AX5Cg
    Twitter
    Twitter
    https://twitter.com/zambonpharma
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    cphi-worldwide-milan-70313.png

    CPhI Worldwide, Milan

    Booth #5B106

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1657787559.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1583380114.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Results of Phase 3 PROMIS-I & PROMIS-II Studies 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-12292.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-62046.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Pipeline

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1063.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Zach Digital Brochure

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1657779912.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Sophisticated Molecules

    read-more

      https://www.pharmacompass.com/pdf/party/content/zach-system-sa-party-content-1632832010.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Zcube Announces 5 Startups For New Edition Focused Women's Health
    Zcube Announces 5 Startups For New Edition Focused Women's Health

    10 Oct 2024

    // PRESS RELEASE

    https://www.zambon.com/sites/default/files/press/files/2024-09/open-accelerator-announces-5-startups-2024-program.pdf

    PRESS RELEASE
    10 Oct 2024
    Share Share
    Zambon Ventures Leads C$2 million investment In Health Innovation
    Zambon Ventures Leads C$2 million investment In Health Innovation

    24 Sep 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-09-24-zcube-zambon-research-venture-leads-c2-million-investment-round-canadian

    PRESS RELEASE
    24 Sep 2024
    Share Share
    Zambon Phase 3 Study Shows Success In CMS I-neb Efficacy In NCFB
    Zambon Phase 3 Study Shows Success In CMS I-neb Efficacy In NCFB

    13 Sep 2024

    // PRESS RELEASE

    https://www.zambon.com/sites/default/files/press/files/2024-09/240913_global_zambon_lancet-promis-1.pdf

    PRESS RELEASE
    13 Sep 2024
    Share Share
    Giovanni Magnaghi is the new Chief Executive Officer of Zambon SpA
    Giovanni Magnaghi is the new Chief Executive Officer of Zambon SpA

    02 May 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-05-02-giovanni-magnaghi-new-chief-executive-officer-zambon-spa

    PRESS RELEASE
    02 May 2024
    Share Share
    Zcube Launches 2024 Open Accelerator For Life Sciences Startups Focusing On Women's Health
    Zcube Launches 2024 Open Accelerator For Life Sciences Startups Focusing On Women's Health

    27 Feb 2024

    // PRESS RELEASE

    https://www.zambon.com/sites/default/files/press/files/2024-02/240227_ENG_Open%20Accelerator%202024%20Launch_DEF.pdf

    PRESS RELEASE
    27 Feb 2024
    Share Share
    Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203
    Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203

    27 Feb 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-02-27-amneal-enters-exclusive-european-licensing-agreement-zambon-biotech-ipx203

    PRESS RELEASE
    27 Feb 2024
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    Analytical

    Discover their expertise for : Analytical

    API Manufacturing

    Discover their expertise for : API Manufacturing

    Lyophilization

    read-more
    read-more